SME

RAPID + TCT Sets Strategic Direction, Releases Schedule for 2024-26 Events

Retrieved on: 
Wednesday, March 20, 2024
Government, TCT, Wood, Growth, Original equipment manufacturer, Partnership, WCX, Research, Artificial intelligence, ASTM, Hollywood Showcase, RAPID, City, Robotics, RSNA, ARMI, SME, 3D printing, Machine learning, SAE, Convention center, Engineering, Printing, Video game

In 2026, RAPID + TCT will take place April 14-16 in Boston for the first time at the Boston Convention & Exhibition Center.

Key Points: 
  • In 2026, RAPID + TCT will take place April 14-16 in Boston for the first time at the Boston Convention & Exhibition Center.
  • “It’s important that we signpost to the industry what our plans are,” said Duncan Wood, Rapid News Group CEO.
  • For more details about this year’s edition of RAPID + TCT, visit rapid3devent.com .
  • Additional details about the 2025 and 2026 editions of RAPID + TCT, including information for exhibitors, will be available soon.

Asia Pacific Foundation of Canada to Lead Partnering for Sustainability: The Canadian Women-only Business Mission to Taiwan and Vietnam

Retrieved on: 
Monday, March 18, 2024
Growth, APF, Woman, SME, Economic development, Management

APF Canada is now accepting delegate applications for this funded mission, part of the Foundation’s 2023-2025 mission series, Northeast X Southeast: Advancing Partnerships Between Canada and Asia.

Key Points: 
  • APF Canada is now accepting delegate applications for this funded mission, part of the Foundation’s 2023-2025 mission series, Northeast X Southeast: Advancing Partnerships Between Canada and Asia.
  • The fall 2024 mission will focus on the technology and innovation sectors to spotlight the ideas and solutions Canadian women entrepreneurs bring to these sectors.
  • Taiwan and Vietnam present ideal market opportunities for Canadian businesses, particularly in the technology and innovation sectors.
  • The Canadian Women-only Business Mission to Taiwan and Vietnam is generously supported by contributions from the Government of Canada through Innovation, Science and Economic Development Canada and the Women Entrepreneurship Strategy .

Lithium Americas Reports 2023 Full Year and Fourth Quarter Results

Retrieved on: 
Friday, March 15, 2024
Lithium, PLA, District court, Bureau, News, Regulation, Public expenditure, Doctor of Philosophy, National instrument, Judgement, Bank statement, TSX, SME, Engineering, Record, Construction

VANCOUVER, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) has reported its financial and operating results for the fourth quarter and year ended December 31, 2023 (“Q4 2023”) and has filed its audited consolidated financial statements (“Financials”) and management’s discussion and analysis (“MD&A”) for the year ended December 31, 2023. The Company is also providing an update on its Thacker Pass lithium project in Humboldt Country, Nevada (“Thacker Pass”).

Key Points: 
  • VANCOUVER, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) has reported its financial and operating results for the fourth quarter and year ended December 31, 2023 (“Q4 2023”) and has filed its audited consolidated financial statements (“Financials”) and management’s discussion and analysis (“MD&A”) for the year ended December 31, 2023.
  • The Company is also providing an update on its Thacker Pass lithium project in Humboldt Country, Nevada (“Thacker Pass”).
  • Site preparation for major earthworks has been completed, including all site clearing, commissioning a water supply system, site access improvements and site infrastructure.
  • The Company is currently focused on advancing detailed engineering, procurement and execution planning for the construction of Thacker Pass Phase 1.

Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance

Retrieved on: 
Thursday, March 14, 2024
B2S, Culture, Government, Education, Software as a service, Intelligence, Course Hero, Entrepreneurship, Sovereign, Human, Student, City, Cisco, Acceleration, Workforce, Computer, SME, Medical device

SINGAPORE, March 14, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, and FatBrain AI (“FatBrain AI”) an AI SaaS and Solutions company (OTCMKTS:LZGI) today announced completion of their merger to form an AI-powered Education and Acceleration group to power Sovereign AI ecosystems of tomorrow for entrepreneurs, enterprises, governments and students through AI education and enablement.

Key Points: 
  • SINGAPORE, March 14, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, and FatBrain AI (“FatBrain AI”) an AI SaaS and Solutions company (OTCMKTS:LZGI) today announced completion of their merger to form an AI-powered Education and Acceleration group to power Sovereign AI ecosystems of tomorrow for entrepreneurs, enterprises, governments and students through AI education and enablement.
  • Following NYSE approval, Genius Group completed the merger, acquiring FatBrain AI in an all-stock transaction.
  • Under the terms of the agreement, Genius Group has acquired the AI software assets, customer relationships and specific operations of FatBrain AI, with an anticipated increase of approximately 150% in the Company’s 2023 pro forma revenue guidance to an estimated $76 million to $80 million, and an anticipated increase of $4 million in pro forma net profit guidance to $7 million to $9 million.
  • Roger Hamilton, CEO of Genius Group said “The demand for AI and entrepreneurial skills continues to grow.

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Retrieved on: 
Thursday, March 14, 2024
Nucleus, Bone marrow, BCMA, BioNTech, B-ALL, Patient, ALL, SLE, Engineering, Minocycline, European Medicines Agency, Therapy, Research, Canadian Aviation Regulations, Flow cytometry, ASH, General counsel, Immunotherapy, SVP, EMA, Legal Affairs, Trial of the century, GMP, SME, BLA, Nature Communications, Development, UCL, Biologics license application, Multiple myeloma, MIA, University College London, Senior, TRBC, GD2, ASCO, FDA, CD19, Conference call, Conference, MAA, EHA, ADS, MHRA, T cell, ACS Chemical Biology, PDUFA, Autoimmune disease, Pharmaceutical industry

“For now, we remain fully focused on preparing for a potential obe-cel launch and successfully transitioning Autolus to a commercial stage company.

Key Points: 
  • “For now, we remain fully focused on preparing for a potential obe-cel launch and successfully transitioning Autolus to a commercial stage company.
  • In February 2024, Autolus promoted Dr. Chris Williams to Chief Business Officer and Alex Driggs to Senior Vice President, Legal Affairs and General Counsel.
  • Dr. Leiderman brings extensive transactional and financial expertise, and Mr. Azelby brings more than 30 years of biopharmaceutical leadership and commercial experience to Autolus’ Board.
  • Financial Results for the Year Ended December 31, 2023

DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution

Retrieved on: 
Thursday, March 14, 2024
Algorithm, IPON, Growth, SME, Intelligence, NRC, Education, Research, IRAP, Software, IP, National Research Council, Intellectual property, Creative industries

The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing CERVAI™ Brain Health AI solution.

Key Points: 
  • The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing CERVAI™ Brain Health AI solution.
  • Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “We have made significant technical and operating progress with CERVAI™, our novel brain health AI solution, and we are pleased to strengthen support of our intellectual property for commercialization with a potential $150,000 non-dilutive funding from IPON and IP Assist programs.
  • As part of our global commercialization plans for CERVAI™, we continue to invest in R&D and expand our intellectual property portfolio through patents, copyrights, trademarks and trade secrets.”
    With the IPON Partner Program, DiagnaMed can receive up to $35,000 in initial funding, with a further total grant of $100,000 for intellectual property protection and commercialization services.
  • DiagnaMed has completed IP Assist Level 1 with the IP Assist program and is eligible to receive up to $50,000 for expert IP services.

Solaris Provides Disclosure Clarifications

Retrieved on: 
Wednesday, March 13, 2024
Copper, GSI, QA/QC, Molybdenum, SLS, Mineral Resources Limited, AAS, ALS, Independent, Disclosure, Inference, Bureau Veritas, MRE, News, Classification, TSX, SME, Gold, Technical report, Mining, Uranium mining

VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is issuing the following news release as a result of a continuous disclosure review by the British Columbia Securities Commission.

Key Points: 
  • VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is issuing the following news release as a result of a continuous disclosure review by the British Columbia Securities Commission.
  • The Company will file an amended technical report as soon as practicable with disclosure relating to the indicative starter pit removed from such disclosure.
  • The Company has also made certain disclosure in its corporate presentation regarding potential economic results for the property and consensus analyst estimates for the MRE.
  • The Company is retracting the foregoing disclosure noted in this paragraph and confirms it has not completed an economic assessment at the project.

Dekube Unveils Revolutionary Decentralized Computing Power Network to Democratize AI Development

Retrieved on: 
Tuesday, March 12, 2024
OpenAI, GPU, SME, Risk, Small, Carbon, LLM, Architecture, Graphics processing unit, Big, Small and medium-sized enterprises, Artificial intelligence, Cryptocurrency

Hong Kong, March 12, 2024 (GLOBE NEWSWIRE) -- In a landmark move poised to change the landscape of Artificial Intelligence (AI) development, Dekube has announced the launch of its decentralized computing power network.

Key Points: 
  • Hong Kong, March 12, 2024 (GLOBE NEWSWIRE) -- In a landmark move poised to change the landscape of Artificial Intelligence (AI) development, Dekube has announced the launch of its decentralized computing power network.
  • AI technology, while advancing rapidly, has been largely dominated by tech giants due to the prohibitive costs of training and developing AI models.
  • In addition to democratizing AI, Dekube addresses the environmental concerns associated with the extensive use of computing resources in AI development.
  • By utilizing idle GPU computing power, Dekube presents a more sustainable model that reduces the carbon footprint associated with AI training and development.

CData Software Acquires Data Virtuality to Modernize Data Virtualization for the Enterprise

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Data Management, Data Analytics, Technology, Software, Networks, Internet, Cloud, BSH, Organization, Growth, Acquisition, NYU, Global 2000, Driver, Fortune 500, CDATA, Data management, SME, Virtual reality, Cryptocurrency

CData Software , a leading provider of data connectivity solutions, today announced the acquisition of Data Virtuality , a global provider of data integration and management solutions.

Key Points: 
  • CData Software , a leading provider of data connectivity solutions, today announced the acquisition of Data Virtuality , a global provider of data integration and management solutions.
  • CData is the only data management vendor to bring a bi-modal integration stack to market, allowing customers to leverage both data replication and live data access within one common connectivity platform.
  • Now, Data Virtuality expands CData’s ability to support organizations with an enterprise-grade data virtualization platform that solves for organization-wide access to live data.
  • “Data Virtuality is proud to share CData’s commitment to empowering businesses to unleash and maximize the full potential of their data,” said Dr. Nick Golovin, founder and CEO of Data Virtuality.

Global Orphan Drug Growth Opportunities Analysis - Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Health, Pharmaceutical, ODD, IRA, Data wrangling, Informatics, Growth, Patient, Public, Neoplasm, Research, Health care, Cancer, ODS, Medicine, Investment, RDS, US FDA, Nanomedicine, RD, Inflation, OD, SME, Multiomics, Pharmaceutical industry

The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • This study provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth.
  • The growing number of unaddressed RD needs is a major catalyst for R&D.
  • There is a need for novel medicine to treat RDs that currently have limited therapeutic choices.